Search research articles
Contact Us
Filters
Showing results (41-50 of 183) with videos related to
Page
of 19
Sort By:
International Journal of Molecular Sciences
|
September 25, 2019
The Roles of Sex Hormones in the Course of Atopic Dermatitis
Naoko Kanda, Toshihiko Hoashi, Hidehisa Saeki
International Journal of Molecular Sciences
|
August 6, 2020
Nutrition and Psoriasis
Naoko Kanda, Toshihiko Hoashi, Hidehisa Saeki
Journal of Dermatological Science
|
May 22, 2013
Suppressive effects of antimycotics on thymic stromal lymphopoietin production in human keratinocytes
Carren S Hau, Naoko Kanda, Shinichi Watanabe
Journal of the American Academy of Dermatology
|
January 29, 2025
A 96-week real-world outcome of upadacitinib treatment for atopic dermatitis: Systemic therapy-naive versus -experienced patients
Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, et al.
Clinical, Cosmetic and Investigational Dermatology
|
March 14, 2022
A Case of Darier's Disease with a Novel Missense Mutation in <i>ATP2A2</i> Successfully Treated with Calcipotriol/Betamethasone Dipropionate Two-Compound Ointment
Teppei Hagino, Hajime Nakano, Hidehisa Saeki, et al.
European Journal of Dermatology : EJD
|
July 22, 2009
Atypical cutaneous sarcoidosis with diffuse, indurated erythema
Yayoi Tada, Naoko Kanda, Takamitsu Ohnishi, et al.
European Journal of Immunology
|
February 3, 2007
IL-18 enhances IFN-gamma-induced production of CXCL9, CXCL10, and CXCL11 in human keratinocytes
Naoko Kanda, Teruo Shimizu, Yayoi Tada, et al.
Journal of the American Academy of Dermatology
|
March 4, 2026
A 144-week real-world outcomes of upadacitinib 30 mg for atopic dermatitis in poor responders to 15 mg
Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
March 11, 2026
Effectiveness of Lebrikizumab Treatment for Patients with Atopic Dermatitis Switched from Dupilumab or Tralokinumab: A 48-Week Real-World Retrospective Study
Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, et al.
The Journal of Dermatological Treatment
|
February 2, 2024
Effectiveness and safety of deucravacitinib treatment for moderate-to-severe psoriasis in real-world clinical practice in Japan
Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, et al.
Page
of 19
Search research articles
Search
Showing results (41-50 of 183) with videos related to
Sort By:
Page
of 19
International Journal of Molecular Sciences
|
September 25, 2019
The Roles of Sex Hormones in the Course of Atopic Dermatitis
Naoko Kanda, Toshihiko Hoashi, Hidehisa Saeki
International Journal of Molecular Sciences
|
August 6, 2020
Nutrition and Psoriasis
Naoko Kanda, Toshihiko Hoashi, Hidehisa Saeki
Journal of Dermatological Science
|
May 22, 2013
Suppressive effects of antimycotics on thymic stromal lymphopoietin production in human keratinocytes
Carren S Hau, Naoko Kanda, Shinichi Watanabe
Journal of the American Academy of Dermatology
|
January 29, 2025
A 96-week real-world outcome of upadacitinib treatment for atopic dermatitis: Systemic therapy-naive versus -experienced patients
Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, et al.
Clinical, Cosmetic and Investigational Dermatology
|
March 14, 2022
A Case of Darier's Disease with a Novel Missense Mutation in <i>ATP2A2</i> Successfully Treated with Calcipotriol/Betamethasone Dipropionate Two-Compound Ointment
Teppei Hagino, Hajime Nakano, Hidehisa Saeki, et al.
European Journal of Dermatology : EJD
|
July 22, 2009
Atypical cutaneous sarcoidosis with diffuse, indurated erythema
Yayoi Tada, Naoko Kanda, Takamitsu Ohnishi, et al.
European Journal of Immunology
|
February 3, 2007
IL-18 enhances IFN-gamma-induced production of CXCL9, CXCL10, and CXCL11 in human keratinocytes
Naoko Kanda, Teruo Shimizu, Yayoi Tada, et al.
Journal of the American Academy of Dermatology
|
March 4, 2026
A 144-week real-world outcomes of upadacitinib 30 mg for atopic dermatitis in poor responders to 15 mg
Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
March 11, 2026
Effectiveness of Lebrikizumab Treatment for Patients with Atopic Dermatitis Switched from Dupilumab or Tralokinumab: A 48-Week Real-World Retrospective Study
Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, et al.
The Journal of Dermatological Treatment
|
February 2, 2024
Effectiveness and safety of deucravacitinib treatment for moderate-to-severe psoriasis in real-world clinical practice in Japan
Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, et al.
Page
of 19